Correlation Between Cipher Pharmaceuticals and IShares Canadian

Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and IShares Canadian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and IShares Canadian into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cipher Pharmaceuticals and iShares Canadian HYBrid, you can compare the effects of market volatilities on Cipher Pharmaceuticals and IShares Canadian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of IShares Canadian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and IShares Canadian.

Diversification Opportunities for Cipher Pharmaceuticals and IShares Canadian

-0.73

Correlation Coefficient

Cipher Pharmaceuticals  IShares Canadian

Pay attention - limited upside

The 3 months correlation between Cipher and IShares is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and iShares Canadian HYBrid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Canadian HYBrid and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with IShares Canadian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Canadian HYBrid has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and IShares Canadian go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and IShares Canadian

Assuming the 90 days trading horizon Cipher Pharmaceuticals is expected to under-perform the IShares Canadian. In addition to that, Cipher Pharmaceuticals is 14.2 times more volatile than iShares Canadian HYBrid. It trades about -0.04 of its total potential returns per unit of risk. iShares Canadian HYBrid is currently generating about 0.19 per unit of volatility. If you would invest  1,927  in iShares Canadian HYBrid on September 2, 2024 and sell it today you would earn a total of  64.00  from holding iShares Canadian HYBrid or generate 3.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cipher Pharmaceuticals  vs.  iShares Canadian HYBrid

Cipher Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

iShares Canadian HYBrid

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Cipher Pharmaceuticals and IShares Canadian

The main advantage of trading using opposite Cipher Pharmaceuticals and IShares Canadian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, IShares Canadian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Canadian will offset losses from the drop in IShares Canadian's long position.

The idea behind Cipher Pharmaceuticals and iShares Canadian HYBrid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.